Ann Clin Microbiol.  2020 Sep;23(3):215-218. 10.5145/ACM.2020.23.3.5.

A Case Report of Saccharomyces cerevisiae Fungemia in a Premature Infant Following Probiotic Treatment

• Lee J
• Kim H
• Lee HK
• Park YJ

• KMID: 2506558
• DOI: http://doi.org/10.5145/ACM.2020.23.3.5

Abstract

Probiotics are used to restore and maintain the healthy intestinal microflora. Although Saccharomyces cerevisiae (SC) is considered as a non-pathogenic yeast, administration of SC as a probiotic is associated with a rare cause of fungemia in immunocompromised patients with central venous catheter insertion. We encountered a case of SC fungemia in a premature infant who presented with respiratory distress syndrome and had undergone central venous catheterization.

Keyword

Central venous catheter; Fungemia; Premature birth; Probiotics; Saccharomyces cerevisiae

Figure

• 

  Fig. 1. Microscopic image (A) and colony morphology (B) of Saccharomyces cerevisiae from the patient’s blood specimen.

Reference

1. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989:365-78.

2. Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, de Vos WM, et al. Demonstration of safety of probiotics-a review. Int J Food Microbiol 1998:93-106.

3. Carroll KC, Pfaller MA, et al. eds. Manual of Clinical Microbiology. 12th ed. American Society for Microbiology; 2019.

4. Hennequin C, Kauffmann-Lacroix C, Jobert A, Viard JP, Ricour C, Jacquemin JL, et al. Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis 2000:16-20.

5. Munoz P, Bouza E, Cuenca-Estrella M, Eiros JM, Perez MJ, Sanchez-Somolinos M, et al. Saccharomyces cerevisiae fungmia:an emrging infectious disease. Clin Infect Dis 2005:1625-34.

6. Pérez-Cantero A, Thomson P, Paredes K, Guarro J, Capilla J. Antifungal susceptibility of Saccharomyces cerevisiae and therapy in a murine model of disseminated infection. Rev Iberoam Micol 2019;36:37-40.

7. Lee HY, Kim JH, Kim SJ, Lee HJ, Kwon JC, Park YJ, et al. Two cases of Saccaharomyces cerevisiae fungemia in patients with hematologic malignancies. Infect Chemother 2012:477-80.

8. Roy U, Jessani LG, Rudramurthy SM, Gopalakrishnan R, Dutta S, Chandrashish C, et al. Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses 2017:375-80.

9. Kim CS. Saccharomyces cerevisiae sepsis after treatment of Saccharomyces boulardii probiotics in premature infants. Korean J Perinatol 2011:52-6.

10. Reid G, Jass J, Sebulsky T, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003:658-72.

11. Lee SJ, Cho SJ, Park EA. Effects of probiotics on enteric flora and feeding tolerance in preterm infants. Neonatology 2007:174-9.

12. Romanio MR, Augusto Coraine LA, Maielo VP, Abramczyc ML, Souza RLD, Oliveira NF. Saccharomyces cerevisiae fungemia in a pediatric patient after treatment with probiotics. Rev Paul Pediatr 2017;35:361-4.

13. Atıcı S, Soysala A, Ceritb KK, Yılmazc Ş, Aksuc B, Kıyanb G, et al. Catheter-related Saccharomyces cerevisiae fungemia following Saccharomyces boulardii probiotic treatment: in a child in intensive care unit and review of the literature. Med Mycol Case Rep 2017;15:33-5.